Literature DB >> 10403932

Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid.

M J Bottomley1, N J Webb, C J Watson, P J Holt, A J Freemont, P E Brenchley.   

Abstract

This study was designed to investigate VEGF production from peripheral blood mononuclear cells (PBMC) from patients with rheumatoid arthritis (RA) compared with healthy controls and to identify the predominant cellular source in PBMC isolated from RA patients. The regulation of PBMC VEGF production by cytokines and synovial fluid (SF) was studied. PBMC were isolated from RA patients and healthy controls and stimulated with lipopolysaccharide (LPS), IL-1beta, IL-4, IL-6, IL-8, IL-10, TNF-alpha and transforming growth factor-beta (TGF-beta) isoforms for varying time points up to 72 h at 37 degrees C/5% CO2. The effect of SF on VEGF secretion by PBMC was also studied. Supernatant VEGF levels were measured using a flt-1 receptor capture ELISA. RA patients had significantly higher spontaneous production of VEGF compared with controls, and monocytes were identified as the predominant cellular source. RA PBMC VEGF production was up-regulated by TGF-beta isoforms and TNF-alpha and down-regulated by IL-4 and IL-10, with no effect observed with IL-1beta, IL-6 and IL-8. Antibody blocking experiments confirmed that TNF-alpha and not TGF-beta isoforms in SF increased VEGF secretion by RA PBMC. These results emphasize the importance of monocytes as a source of VEGF in the pathophysiology of RA. Several cytokines known to be present in SF can modulate the level of VEGF secretion, but the predominant effect of SF in VEGF up-regulation is shown to be dependent on TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403932      PMCID: PMC1905470          DOI: 10.1046/j.1365-2249.1999.00949.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

2.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.

Authors:  M R Freeman; F X Schneck; M L Gagnon; C Corless; S Soker; K Niknejad; G E Peoples; M Klagsbrun
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

3.  Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.

Authors:  M Detmar; K T Yeo; J A Nagy; L Van de Water; L F Brown; B Berse; B M Elicker; S Ledbetter; H F Dvorak
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

4.  Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation.

Authors:  G Janossy; G Panayi; O Duke; M Bofill; L W Poulter; G Goldstein
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

5.  Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis.

Authors:  M Nagashima; S Yoshino; T Ishiwata; G Asano
Journal:  J Rheumatol       Date:  1995-09       Impact factor: 4.666

6.  Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry.

Authors:  J C Cooper; A M Sharkey; J McLaren; D S Charnock-Jones; S K Smith
Journal:  J Reprod Fertil       Date:  1995-11

7.  Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro.

Authors:  S Koochekpour; A Merzak; G J Pilkington
Journal:  Cancer Lett       Date:  1996-04-19       Impact factor: 8.679

8.  Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

Authors:  B Olofsson; K Pajusola; A Kaipainen; G von Euler; V Joukov; O Saksela; A Orpana; R F Pettersson; K Alitalo; U Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia.

Authors:  G T Stavri; I C Zachary; P A Baskerville; J F Martin; J D Erusalimsky
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

10.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Authors:  V Joukov; K Pajusola; A Kaipainen; D Chilov; I Lahtinen; E Kukk; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

View more
  18 in total

Review 1.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 3.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 4.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 5.  [Growth factors].

Authors:  N Hunzelmann; S Eming; S Rosenkranz
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

6.  Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.

Authors:  T Hoeres; M Wilhelm; M Smetak; E Holzmann; G Schulze-Tanzil; J Birkmann
Journal:  Clin Exp Immunol       Date:  2018-01-04       Impact factor: 4.330

7.  Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA).

Authors:  T Kasama; K Kobayashi; N Yajima; F Shiozawa; Y Yoda; H T Takeuchi; Y Mori; M Negishi; H Ide; M Adachi
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

8.  Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes.

Authors:  Peter Brenneisen; Ralf Blaudschun; Jens Gille; Lars Schneider; Ralf Hinrichs; Meinhard Wlaschek; Sabine Eming; Karin Scharffetter-Kochanek
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

9.  Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

Authors:  Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Mod Rheumatol       Date:  2008-11-01       Impact factor: 3.023

10.  Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.

Authors:  Stacy M Plum; Eun J Park; Steve J Strawn; Elizabeth G Moore; Carolyn F Sidor; William E Fogler
Journal:  BMC Musculoskelet Disord       Date:  2009-05-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.